Related Experiment Video
Updated: Jun 25, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
[Cardiac failure secondary to idiopathic hypoparathyroidism: a case report]
Filiz Ozerkan1, Hasan Güngör, Mehdi Zoghi
1Ege Universitesi Tip Fakültesi, Kardiyoloji Anabilim Dali, Izmir, Turkey. fozerkan@yahoo.com
Insights
Hypoparathyroidism can cause severe heart failure due to low calcium (hypocalcemia), which is often resistant to standard treatments. Prompt calcium and vitamin D supplementation can rapidly reverse cardiac dysfunction in these rare cases.
Area of Science:
- Cardiology
- Endocrinology
- Internal Medicine
Background:
- Hypocalcemic cardiomyopathy, a rare condition, results from hypoparathyroidism leading to heart failure.
- Heart failure secondary to hypocalcemia is often refractory to conventional therapies.
Observation:
- A 41-year-old man presented with cardiac failure attributed to hypocalcemia from idiopathic hypoparathyroidism.
- Echocardiography revealed biventricular dysfunction, chamber dilation, pulmonary hypertension, and valvular regurgitation.
Findings:
- Serum calcium and parathyroid hormone levels were significantly low.
- Treatment with calcium and vitamin D supplementation led to rapid improvement in heart failure symptoms and echocardiographic findings.
- Biventricular systolic and diastolic functions normalized within 6 months.
Implications:
- Monitoring serum calcium is crucial for patients with cardiac failure.
- Hypocalcemia should be considered in the differential diagnosis of refractory heart failure.
- Early diagnosis and treatment of hypocalcemia can restore cardiac function.
Abstract:
Hypocalcemic cardiomyopathy due to hypoparathyroidism is a very rare condition. Ensuing heart failure due to hypocalcemia is refractory to conventional treatment. We reported a 41-year-old man who developed cardiac failure due to hypocalcemia secondary to idiopathic hypoparathyroidism. Echocardiography showed biventricular low ejection fraction, dilated heart chambers, pulmonary hypertension, and valvular regurgitations. Serum calcium and parathyroid hormone levels were low. After treatment of heart failure and calcium-vitamin D supplementation, signs and symptoms of heart failure improved rapidly. At 6 months, biventricular systolic and diastolic functions returned to normal. Serum calcium level should be monitored in every patient with cardiac failure and hypocalcemia should be considered in patients with refractory heart failure.
Related Concept Videos
Hypothyroidism II: Pathophysiology
Heart Failure I: Introduction
Hyperthyroidism II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
